France In Vitro Fertilization Market Size & Outlook
Global Market
Related Markets
France in vitro fertilization market highlights
- The France in vitro fertilization market generated a revenue of USD 1,505.2 million in 2025 and is expected to reach USD 1,980.5 million by 2033.
- The France market is expected to grow at a CAGR of 3.37% from 2026 to 2033.
- In terms of segment, frozen nondonor was the largest revenue generating procedure type in 2025.
- Frozen Nondonor is the most lucrative procedure type segment registering the fastest growth during the forecast period.
In vitro fertilization market data book summary
| Market revenue in 2025 | USD 1,505.2 million |
| Market revenue in 2033 | USD 1,980.5 million |
| Growth rate | 3.37% (CAGR from 2026 to 2033) |
| Largest segment | Frozen nondonor |
| Fastest growing segment | Frozen Nondonor |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
| Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
Other key industry trends
- In terms of revenue, France accounted for 5.2% of the global in vitro fertilization market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany in vitro fertilization market is projected to lead the regional market in terms of revenue in 2033.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 2,608.0 million by 2033.
In France, a majority of fertility treatments involve the use of intra-partner gametes, and the use of donated gametes is very rare. The prevalence of infertility has been on the rise in France, contributing to the demand for IVF treatments. Various factors, such as lifestyle changes, environmental factors, and medical conditions, can impact fertility, leading more individuals and couples to seek fertility assistance.
According to a report presented in 2022 to the Ministry of Health, infertility is considered a significant public health issue in France, affecting one in four couples of childbearing age. Government initiatives in France are expected to stimulate and enhance the demand for fertility treatments, including IVF.
These initiatives aim to address the growing concern surrounding infertility as a public health issue and provide support for couples facing fertility challenges. For instance, in June 2021, the lower house of parliament in France officially passed a law granting single women and lesbian couples access to medically assisted reproduction.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
In Vitro Fertilization Market Scope
In Vitro Fertilization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Boston Scientific Corp | View profile | 48,000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | www.bostonscientific.com |
| Vitrolife AB ADR | View profile | 1,116 | Box 9080, Gothenburg, Sweden, 400 92 | www.vitrolife.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| The Cooper Companies Inc | View profile | 15,000 | 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, United States, 94583 | www.coopercos.com |
| Genea Biomedx | View profile | 101-250 | Sydney, New South Wales, Australia, Oceania | www.geneabiomedx.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | www.cookmedical.com |
France In Vitro Fertilization Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In Vitro Fertilization Market Outlook will help companies and investors design strategic landscapes.
Frozen Nondonor was the largest segment with a revenue share of 50.97% in 2025.
Horizon Databook has segmented the France in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2021 to 2033.
In France, a majority of fertility treatments involve the use of intra-partner gametes, and the use of donated gametes is very rare. The prevalence of infertility has been on the rise in France, contributing to the demand for IVF treatments. Various factors, such as lifestyle changes, environmental factors, and medical conditions, can impact fertility, leading more individuals and couples to seek fertility assistance.
According to a report presented in 2022 to the Ministry of Health, infertility is considered a significant public health issue in France, affecting one in four couples of childbearing age. Government initiatives in France are expected to stimulate and enhance the demand for fertility treatments, including IVF.
These initiatives aim to address the growing concern surrounding infertility as a public health issue and provide support for couples facing fertility challenges. For instance, in June 2021, the lower house of parliament in France officially passed a law granting single women and lesbian couples access to medically assisted reproduction.
- France In Vitro Fertilization Market Procedure Type Outlook (Revenue, USD Million , 2021-2033)
- Fresh Nondonor
- Frozen Nondonor
- Fresh Donor
- Frozen Donor
- France In Vitro Fertilization Market Providers Outlook (Revenue, USD Million , 2021-2033)
- Fertility Clinics
- Hospitals and Other Settings
Reasons to subscribe to In Vitro Fertilization Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In Vitro Fertilization Market Outlook databook
- Our clientele includes a mix of In Vitro Fertilization Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France In Vitro Fertilization Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France In Vitro Fertilization Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
France In Vitro Fertilization Market, 2021-2033 (US$M)
France in vitro fertilization market statistics, by procedure type, 2021-2033 (US$M)
